Numbers by Barron's

General Mills Reports $4.5 Billion in Quarterly Sales

Episode Summary

General Mills beats expectations. Biogen's latest drug disappoints. And a look at three newly public companies. Host: Shaina Mishkin. Producer: Katie Ferguson.

Episode Notes

General Mills beats expectations. Biogen's latest drug disappoints. And a look at three newly public companies. Host: Shaina Mishkin. Producer: Katie Ferguson.